Quotation Bilger, Marcel, Wong, Tina, Lee, Jia Yi, Howard, Kaye, Bundoc, Filipinas, Lamoureux, Ecosse, Finkelstein, Eric. 2019. Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial. Applied Health Economics and Health Policy. 17 841-855.


RIS


BibTeX

Abstract

BACKGROUND: Poor adherence to medications is a global public health concern with substantial health and cost implications, especially for chronic conditions. In the USA, poor adherence is estimated to cause 125,000 deaths and cost $US100 billion annually. The most successful adherence-promoting strategies that have been identified so far have moderate effect, are relatively costly, and raise availability, feasibility, and/or scalability issues. OBJECTIVE: The main objective of SIGMA (Study on Incentives for Glaucoma Medication Adherence) was to measure the effectiveness on medication adherence of a novel incentive strategy based on behavioral economics that we refer to as adherence-contingent rebates. These rebates offered patients a near-term benefit while leveraging loss aversion and regret and increasing the salience of adherence. METHODS: SIGMA is a 6-month randomized, controlled, open-label, single-center superiority trial with two parallel arms. A total of 100 non-adherent glaucoma patients from the Singapore National Eye Centre were randomized into intervention (adherence-contingent rebates) and usual care (no rebates) arms in a 1:1 ratio. The primary outcome was the mean change from baseline in percentage of adherent days at Month 6. The trial registration number is NCT02271269 and a detailed study protocol has been published elsewhere. FINDINGS: We found that participants who were offered adherence-contingent rebates were adherent to all their medications on 73.1% of the days after 6 months, which is 12.2 percentage points (pā€‰=ā€‰0.027) higher than in those not receiving the rebates after controlling for baseline differences. This better behavioral outcome was achieved by rebates averaging 8.07 Singapore dollars ($US5.94 as of 2 November 2017) per month during the intervention period. CONCLUSION: This study shows that simultaneously leveraging several insights from behavioral economics can significantly improve medication adherence rates. [...]

Tags

Press 'enter' for creating the tag

Publication's profile

Status of publication Published
Affiliation WU
Type of publication Journal article
Journal Applied Health Economics and Health Policy
Citation Index SCI
WU-Journal-Rating new STRAT-B, WH-B
Language English
Title Using Adherence-Contingent Rebates on Chronic Disease Treatment Costs to Promote Medication Adherence: Results from a Randomized Controlled Trial
Volume 17
Year 2019
Page from 841
Page to 855
Reviewed? Y
DOI http://dx.doi.org/10.1007/s40258-019-00497-0
Open Access Y
Open Access Link https://link.springer.com/article/10.1007/s40258-019-00497-0

Associations

People
Bilger, Marcel (Details)
External
Bundoc, Filipinas (Duke-NUS Medical School, Singapore)
Finkelstein, Eric (Duke-NUS Medical School, Singapore)
Howard, Kaye (Duke-NUS Medical School, Singapore)
Lamoureux, Ecosse (Duke-NUS Medical School, Singapore)
Lee, Jia Yi (SIngapore National Eye Centre, Singapore)
Wong, Tina (SIngapore National Eye Centre, Singapore)
Organization
Health Economics and Policy Group AB (Details)
Google Scholar: Search